Inicio › Cáncer de pulmón › Virginia › Arlington
Ensayos clínicos de Cáncer de pulmón en Arlington, VA
40 estudios para Cáncer de pulmón buscan participantes en centros de Arlington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
ReclutandoFase 3
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · A 5 mi de distancia
A Study of PHN-012 in Patients With Advanced Solid Tumors
ReclutandoFase 1
- PHN-012-001 Site, Fairfax · A 11 mi de distancia
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
ReclutandoFase 3
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
ReclutandoFase 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · A 11 mi de distancia
- Inova Schar Cancer, Fairfax · A 11 mi de distancia
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
ReclutandoFase 2
- Research Site, Fairfax · A 11 mi de distancia
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ReclutandoFase 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
ReclutandoFase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · A 11 mi de distancia
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
ReclutandoFase 3
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
ReclutandoFase 1
- NEXT - Virginia, Fairfax · A 11 mi de distancia
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- USO - Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- USO-Virginia Cancer Specialists, PC, Fairfax · A 11 mi de distancia
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · A 11 mi de distancia
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
ReclutandoFase 3
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
ReclutandoFase 3
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ReclutandoFase 3
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
ReclutandoFase 1
- Research Site, Fairfax · A 11 mi de distancia
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ReclutandoFase 1
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · A 5 mi de distancia
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutandoFase 1/2
- Next Oncology Virginia, Fairfax · A 11 mi de distancia
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
ReclutandoFase 1/2
- NEXT Oncology, Fairfax · A 11 mi de distancia
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · A 5 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · A 5 mi de distancia
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
ReclutandoFase 2
- Inova Fairfax Hospital, Fairfax · A 11 mi de distancia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Más información sobre Cáncer de pulmón en MedlinePlus
Ensayos de Cáncer de pulmón en otras ciudades
- Houston, TX78 estudios
- Boston, MA62 estudios
- New York City, NY60 estudios
- Los Angeles, CA45 estudios
- Washington, DC41 estudios
- Chicago, IL41 estudios
- Nashville, TN40 estudios
- Baltimore, MD40 estudios
- St. Louis, MO39 estudios
- Columbus, OH36 estudios
- Philadelphia, PA36 estudios
- Seattle, WA33 estudios
Otros estudios en Arlington
- Cáncer de pulmón de células no pequeñas104 estudios
- Cáncer metastásico53 estudios
- Cáncer del colon y del recto52 estudios
- Cáncer (todos los tipos)48 estudios
- Cáncer de ovario46 estudios
- Cáncer de seno46 estudios
- Cáncer de endometrio39 estudios
- Cáncer de páncreas34 estudios
- Carcinoma de células escamosas de cabeza y cuello26 estudios
- Cáncer de pulmón de células pequeñas23 estudios
- Melanoma20 estudios
- Cáncer de mama triple negativo20 estudios
De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.